Pharmaceutical Products
603139-19-1;Odanacatib;MK-0822;MK 0822;MK0822
603139-19-1;Odanacatib;MK-0822;MK 0822;MK0822
Description
Odanacatib (MK 0822) is an inhibitor of cathepsin K with potential anti-osteoporotic activity. Odanacatib selectively binds to and inhibits the activity of cathepsin K (IC50=0.2nM), which may result in a reduction in bone resorption, improvement of bone mineral density, and a reversal in osteoporotic changes. Odanacatib is currently in clinical development for the treatment of postmenopausal osteoporosis.
http://www.chemscene.com/Odanacatib.html
Read More
ChemScene, LLC
ChemScene Pharmaceutical chemical
Address: 11 Deer Park Drive, Suite 102A, Monmouth Junction, NJ 08852,
jersey, new jersey
United States, 07097
Tel: 732-484-9848
Fax: